DoH published revised agenda for July 2024 PBAC meeting (12 April 2024)

12 April 2024 - Version 2 of the agenda for the July 2024 PBAC meeting is now available; two minor ...

Read more →

PureTech receives FDA fast track designation for LYT-200 in head and neck cancers

11 April 2024 - LYT-200 is being evaluated in locally advanced/metastatic solid tumours, including head and neck cancers, as well as ...

Read more →

Fasenra approved for treatment of children aged 6 to 11 with severe asthma

11 April 2024 - AstraZeneca’s Fasenra (benralizumab) is now approved by the US FDA for add-on maintenance treatment for patients ...

Read more →

170,000 people in England to have further treatment choice for preventing migraine attacks

11 April 2024 - In final draft guidance published today NICE has recommended atogepant, the first of a new type of ...

Read more →

Children and young adults to benefit after NICE recommends personalised immunotherapy to treat blood cancer be made routinely available on the NHS

11 April 2024 - Innovative CAR-T therapy recommended to treat an aggressive form of leukaemia. ...

Read more →

'Really expensive': migraine expert calls for more funded treatments

10 April 2024 - Migraine experts are advocating for PHARMAC to fund a new generation of migraine drugs that target ...

Read more →

Why won’t health insurance companies pay for new drugs?

10 April 2024 - The FDA is doing its part to fast-track new treatments, but insurers are standing in the way ...

Read more →

AdrenoMed receives FDA fast track designation for enibarcimab for treatment of septic shock

10 April 2024 - AdrenoMed today announced that the US FDA has granted fast track designation to its lead product candidate ...

Read more →

ICER releases draft evidence report on treatment for chronic obstructive pulmonary disease

10 April 2024 - Public comment period now open until 7 May 2024; requests to make oral comment during public ...

Read more →

New target zero initiative aims to help improve access to new drugs

9 April 2024 - Target Zero is a new initiative that aims to improve the time to access for patients ...

Read more →

AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS

3 April 2024 - AB Science today announced that Health Canada has granted eligibility for reconsideration request for masitinib in ...

Read more →

FDA accepts filing of new drug application for nalmefene auto-injector for the treatment of known or suspected opioid overdose

8 April 2024 - Purdue Pharma announced today that FDA has accepted for filing the company’s new drug application for the ...

Read more →

Lundbeck and Otsuka submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD

9 April 2024 - Lundbeck and Otsuka have submitted a supplemental new drug application for US FDA review of brexpiprazole ...

Read more →

Calls for supplement to treat rare metabolic disorder to be relisted on PBS

10 April 2024 - An Adelaide mother says a vital supplement that assists her sons with a rare metabolic disorder ...

Read more →

Mum’s plea: ‘I’m dying but $7.70 could save my kids’

10 April 2024 - Amelia Ramsay has battled all her life – and now she may have to watch her kids ...

Read more →

Cabozantinib maleate in combination with nivolumab for the first-line treatment of patients with advanced renal cell carcinoma

10 April 2024 - NICE has published final evidence-based recommendations on the use of cabozantinib maleate (Cabometyx) in combination with ...

Read more →